Waleed H. Hassanein, President & CEO at TransMedics Group, Inc. (TMDX), sold 12,000 shares at $95.09 ($1.1M) on 2024-04-10, disclosed to the SEC on 2024-04-12.
Scheduled sale ($1.1M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TMDX | SELL | 2024-10-17 | $2.1M | — | Filing → |
| TMDX | SELL | 2024-09-17 | $2.6M | — | Filing → |
| TMDX | SELL | 2024-08-23 | $7.8M | — | Filing → |